← Open Payments lookup

GAYANEH GHARAKHANI: Open Payments

NPI 1124638663 · GLENDALE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,090 in 37 payments from 11 companies in 2025. Trend: 2023 $162 · 2024 $710 · 2025 $1,090

Food & beverage: $1,090
CompanyPaymentsAmount
Madrigal Pharmaceuticals6$246
Janssen Biotech, Inc.13$209
Ardelyx, Inc.2$155
Lilly USA, LLC1$106
ABBVIE INC.3$96
Salix Pharmaceuticals, a division of Bausch Health US, LLC4$79
Celltrion USA Inc.2$60
QOL Medical, LLC2$46
Aimmune Therapeutics, Inc.2$44
Novo Nordisk Inc1$31

Products named: REZDIFFRA, TREMFYA, IBSRELA, OMVOH, XIFAXAN, LINZESS, VEGZELMA, Sucraid.

Industry payments across CA — which companies pay providers there.